posted Jun 25, 2014, 9:04 AM by Scott Salisbury
|Insys Therapeutics Receives FDA Orphan Drug Designation for Its PharmaceuticalCannabidiol as ...|
PHOENIX, AZ--(Marketwired - Jun 25, 2014) - Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that is developing and ...
|Novagant, Inc. Enters Potential $8.4 Billion Medical Cannabis Industry With an All Legal Medical ...|
Cannabidiol is looked for its "potential as a treatment for a wide range of conditions, including rheumatoid arthritis, diabetes, alcoholism, MS, chronic ...
|( NXTTF N ) Next Gen's GreenRush Financial Conference announces Impressive Lineup of Speakers|
... strain of the cannabis plant with low Tetrahydrocannabinol (THC) and high Cannabidiol (CBD) content which became known as "Charlotte's Web.
|Wednesday's Top Health Care Stories: Aerie, Insys, and Owens & Minor|
Shares of Insys are up more than 5% in pre-market trading, after the FDA granted an orphan drug designation to pharmaceutical cannabidiol (CBD), ...